The Priority Review

Tag

R-Pharm

1 story

  1. Clinical trials

    R-Pharm registers Phase 3 study of Goflikicept in pediatric FMF

    The study plans to enroll 18 participants and plans to begin in December 2026, with primary completion projected for May 2029. It aims to evaluate the pharmacokinetics, efficacy, and safety of goflikicept in children and adolescents with colchicine-resistant or colchicine-intolerant familial Mediterranean fever.